Oxygen depletion during and after mTHPC-mediated photodynamic therapy in RIF1 and H-MESO1 tumors

Radiation Research

Volumn 159, Issue 2, 2003, Pages 190-198

  Schouwink, Hugo ^a   Oppelaar, Hugo ^a   Ruevekamp, Marjan ^a   Van der Valk, Martin ^a   Hart, Guus ^a   Rijken, Paul ^b   Baas, Paul ^a   Stewart, Fiona A ^a,c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; MOUSE; NECROSIS; NONHUMAN; OXYGEN CONSUMPTION; OXYGENATION; PHOTODYNAMIC THERAPY; POLAROGRAPHY; PRIORITY JOURNAL;

ANIMALS; ANOXIA; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OXYGEN; PARTIAL PRESSURE; PHOTOCHEMOTHERAPY; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0037314626     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2003)159[0190:ODDAAM]2.0.CO;2     Document Type: Article

References (44)

1. K. F. Fan, C. Hopper, P. M. Speight, G. A. Buonaccorsi and S. G. Bown, Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int. J. Cancer 73, 25-32 (1997).
2. I. B. Tan, H. Oppelaar, M. C. Ruevekamp-Helmers, A. Timmers and F. A. Stewart, The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck 21, 434-441 (1999).
3. Y. Hayatta, H. Karo, K. Furuse, Y. Kusunoki, S. Suzuki and S. Mimura, Photodynamic therapy of early stage cancers of the lung and oesophagus: A Japanese multi-centre study. Lasers Med. Sci. 11, 255-259 (1996).
4. P. Grosjean, G. Wagnieres, C. Fontolliet, H. van den Bergh and P. Monnier, Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br. J. Cancer 77, 1989-1995 (1998).
5. D. J. Roberts and F. Cairnduff, Photodynamic therapy of primary skin cancer: A review. Br. J. Plast. Surg. 48, 360-370 (1995).
6. A. F. Hurlimann, G. Hanggi and R. G. Panizzon, Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology 197, 248-254 (1998).
7. P. Baas, mTHPC mediated photodynamic therapy in basal cell carcinoma. A phase I study. Br. J. Dermatol., in press.
8. H. I. Pass, T. F. DeLaney, Z. Tochner, P. E. Smith, B. K. Temeck, H. W. Pogrebniak, K. C. Kranda, A. Russo, W. S. Frauf and J. W. Cole, Intrapleural photodynamic therapy: Results of a phase I trial. Ann. Surg. Oncol. 1, 28-37 (1994).
9. H. Takita, T. S. Mang, G. M. Loewen, J. G. Raghaven, J. R. Grajek and T. J. Dougherty, Operation and intracavitary photodynamic therapy for malignant mesothelioma: A phase II study. Ann. Thorac. Surg. 58, 995-998 (1994).
10. P. Baas, L. Murrer, F. A. Zoetmulder, F. A. Stewart, H. B. Ris, N. Van Zandwijk, J. L. Peterse and E. J. Rutgers, Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br. J. Cancer 76, 819-826 (1997).
11. H. B. Ris, H. J. Altermatt, B. Nachbur, C. M. Stewart, Q. Wang, C. K. Lim, R. Bonnett and U. Althaus, Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg. Med. 18, 39-45 (1996).
12. J. H. Schouwink, E. T. Rutgers, J. Van der Sijp, H. Oppelaar, N. Van Zandwijk, R. van Veen, S, Burgers, F. A. Stewart, F. A. Zoetmulder and P. Baas, Intra-operative photodynamic therapy in patients with malignant pleural mesothelioma: Dose finding and toxicity results. Chest 120, 1167-1174 (2001).
13. C. S. Foote, Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54, 659-659 (1991).
14. B. J. Tromberg, A. Orenstein, S. Kimel, S. J. Barker, J. Hyatt, J. S. Nelson and M. W. Berns, In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 52, 375-385 (1990).
15. T. H. Foster, R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson and R. Hilf, Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126, 296-303 (1991).
16. S. A. Blant, A. Woodtli, C. Fontolliet, H. Van den Bergh and P. Monnier, In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 64, 963-968 (1996).
17. I. P. J. Van Geel, H. Oppelaar, P. F. J. W. Rijken, H. J. J. A. Bernsen, N. E. M. Hagemeier, A. J. van der Kogel, R. J. Hodgkiss and F. A. Stewart, Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br. J. Cancer 73, 288-293 (1996).
18. T. M. Sitnik, J. A. Hampton and B. W. Henderson, Reduction of tumour oxygenation during and after photodynamic therapy in vivo: Effects of fluence rate. Br. J. Cancer 77, 1386-1394 (1998).
19. W. M. Star, H. P. A. Marijnissen, A. E. Van den Berg-Blok, J. A. Versteeg, K. A. P. Franken and H. S. Reinhold, Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46, 2532-2540 (1986).
20. I. P. van Geel, H. Oppelaar, J. P. A. Marijnissen and F. A. Stewart, Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. Radiat. Res. 145, 602-609 (1996).
21. T. M. Busch, S. M. Hahn, S. M. Evans and C. J. Koch, Depletion of tumor oxygenation during photodynamic therapy: Detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]. Cancer Res. 60, 2636-2642 (2000).
22. P. R. Twentyman, J. M. Brown, J. W. Gray, A. J. Franko, M. A. Scoles and R. F. Kallman, A new mouse tumor model system (RIF-1) for comparison of end-point studies. J. Natl. Cancer Inst. 64, 595-604 (1980).
23. 2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
24. J. D. Chapman, C. C. Stobbe, M. R. Arnfield, R. Santus, J. Lee and M. S. McPhee, Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res. 126, 73-79 (1991).
25. P. F. J. W. Rijken, H. J. J. A. Bernsen, J. P. W. Peter, R. J. Hodgkiss, J. A. Raleigh and A. J. van der Kogel, Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48, 571-582 (2000).
26. V. H. Fingar, T. J. Wieman and K. W. Doak, Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 50, 2599-2603 (1990).
27. V. H. Fingar, T. J. Wieman and P. S. Haydon, The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin. Photochem. Photobiol. 66, 513-517 (1997).
28. K. S. McMahon, T. J. Wieman, P. H. Moore and V. H. Fingar, Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res. 54, 5374-5379 (1994).
29. Y. Yamamoto, H. Shibuya, T. Okunaka, K. Aizawa and H. Kato, Fibrin plugging as a cause of microcirculatory occlusion during photodynamic therapy. Lasers Med. Sci. 14, 129-135 (1999).
30. T. M. Sitnik and B. W. Henderson, The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol. 67, 462-466 (1998).
31. H. B. Stone, J. M. Brown, T. L. Phillips and R. M. Sutherland, Oxygen in human tumors: Correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat. Res. 136, 422-434 (1993).
32. P. Vaupel and M. Hockel, Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance. Int. J. Oncol. 17, 869-879 (2000).
33. D. M. Brizel, G. L. Rosner, L. R. Prosnitz and M. W. Dewhirst, Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int. J. Radiat. Oncol. Biol. Phys. 32, 1121-1125 (1995).
34. B. M. Seddon, D. J. Honess, B. Vojnovic, G. M. Tozer and P. Workman, Measurement of tumor oxygenation: In vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumor. Radiat. Res. 155, 837-846 (2001).
35. H. Rezzoug, M. Barberi-Heyob, J. L. Merlin, L. Bolotine, D. Lignon and F. Guillemin, In vitro comparison of the photodynamic activity of meso-tetra (m-hydroxyphenyl) chlorin and hematoporphyrin derivative. Bull. Cancer 83, 816-822 (1996).
36. I. P. J. Van Geel, H. Oppelaar, Y. G. Oussoren and F. A. Stewart, Photosensitizing efficacy of MTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int. J. Cancer 60, 388-394 (1994).
37. 3H]misonidazole binding and paired survival assay. Radiat. Res. 145, 491-500 (1996).
38. 2 measurements with hypodermic needle probes. In Clinical Oxygen Pressure Measurement (A. M. Ehrly, W. Flechenstein, J. Hauss and R. Much, Eds.), pp. 38-51. Blackwell Uebereuter Wissenschaft, Berlin, 1990.
39. 2-histography. Int. J. Radiat. Oncol. Biol. Phys. 19, 953-961 (1990).
40. B. W. Henderson and V. H. Fingar, Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47, 3110-3114 (1987).
41. W. T. Jenkins, S. M. Evans and C. J. Koch, Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: Comparative measurements using EF5 binding and the Eppendorf needle electrode. Int. J. Radiat. Oncol. Biol. Phys. 46, 1005-1017 (2000).
42. M. R. Horsman, A. A. Khalil, D. W. Siemann, C. Grau, S. A. Hill, E. M. Lynch, D. J. Chaplin and J. Overgaard, Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 29, 439-442 (1994).
43. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
44. H. Schouwink, M. Ruevekamp, H. Oppelaar, R. van Veen, P. Baas and F. A. Stewart, Photodynamic therapy for malignant mesothelioma: Preclinical studies for optimization of treatment protocols. Photochem. Photobiol. 73, 410-417 (2001).